large granular lymphocyte leukaemia
Recently Published Documents


TOTAL DOCUMENTS

49
(FIVE YEARS 1)

H-INDEX

16
(FIVE YEARS 0)

2021 ◽  
pp. jclinpath-2020-207191
Author(s):  
Alasne Uranga ◽  
Carmen González ◽  
J R Furundarena ◽  
Naiara Robado ◽  
Mercedes Rey ◽  
...  

IntroductionLarge granular lymphocyte (LGL) leukaemia is considered a mature T-cell or natural killer (NK) cell neoplasm, characterised by a clonal proliferation of LGL.AimsTo analyse the characteristics and to establish (if possible) the prognostic parameters of these patients diagnosed in a single centre: University Hospital of Donostia.MethodsWe retrospectively studied data about 308 patients with LGL leukaemia diagnosed in our centre.ResultsThe frequency of T-LGL leukaemia and chronic lymphoproliferative disorder of NK cells was 89% and 6.8% respectively, and no aggressive NK-LGL leukaemia was seen in our population. The median age at diagnosis was 65.7 years and male-to-female ratio was 1.08. 59% of our patients were asymptomatic at the time of diagnosis. Most patients presented lymphocytosis and 63.6% more than 20% LGLs in the peripheral blood count, but it has to be taken into account that these results may be influenced by the selection bias of our study, as we recognised these patients as ‘alarms of the laboratory analysers’. Neutropenia was the most common cytopenia, and autoimmune disorders were described in 16.5% of the patients. Only 12 patients (3.9%) required treatment, a much lower percentage that the one reported in the literature, and this is consistent with the fact that patients were less symptomatic than in other series, as we expected. The 5-year and 15-year overall survival was 92% and 87%, respectively.ConclusionsOur patients may represent the even more benign end of the spectrum of clonal T LGL and NK proliferations.


2020 ◽  
Vol 190 (3) ◽  
pp. 405-417 ◽  
Author(s):  
Francis R. LeBlanc ◽  
Jennifer M. Pearson ◽  
Su‐Fern Tan ◽  
HeeJin Cheon ◽  
Jeffrey C. Xing ◽  
...  

Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos ◽  
Hassan Al-Sader

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)


2018 ◽  
Vol 17 (4) ◽  
pp. 489 ◽  
Author(s):  
Ricardo Ruiz-Villaverde ◽  
Ahinoa Bueno-Rodriguez ◽  
Paula Aguayo-Carreras ◽  
Daniel Sánchez-Cano ◽  
Norberto Ortego-Centeno

NA


2017 ◽  
pp. bcr-2017-220051
Author(s):  
Giulia Biolo ◽  
Giorgia Sacco ◽  
Irene Russo ◽  
Mauro Alaibac

2016 ◽  
Vol 12 (4) ◽  
pp. 239-240
Author(s):  
María del Mar Herráez-Albendea ◽  
María del Castillo Jarilla-Fernández ◽  
Francisco Jiménez-Burgos ◽  
Elisa Sánchez-Rodriguez

Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)


2015 ◽  
Vol 94 (7) ◽  
pp. 1245-1246 ◽  
Author(s):  
Carol Y. M. Cheung ◽  
Alvin H. W. Ip ◽  
Pui-Leung Iu ◽  
Elaine Y. P. Lee ◽  
Yok-Lam Kwong

Sign in / Sign up

Export Citation Format

Share Document